These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 15710256)

  • 21. [The antiphospholipid syndrome in the 21st century].
    Ruiz-Irastorza G; Martinez-Berriotxoa A; Egurbide MV
    Med Clin (Barc); 2009 Sep; 133(10):390-6. PubMed ID: 19375117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome).
    Hoppe B; Burmester GR; Dörner T
    Curr Opin Rheumatol; 2011 May; 23(3):299-304. PubMed ID: 21346577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Aspirin and antiphospholipid syndrome].
    Hachulla E; Piette AM; Hatron PY; Blétry O
    Rev Med Interne; 2000 Mar; 21 Suppl 1():83s-88s. PubMed ID: 10763209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombophilia: implications for pregnancy outcome.
    Greer IA
    Thromb Res; 2003 Jan; 109(2-3):73-81. PubMed ID: 12706634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Factor V Leiden mutation and pregnancy complications].
    Abraitis V; Mongirdiene A; Mockeviciene A
    Medicina (Kaunas); 2003; 39(9):823-9. PubMed ID: 14515043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulants to prevent recurrent placenta-mediated pregnancy complications: Is it time to put the needles away?
    Skeith L; Rodger M
    Thromb Res; 2017 Mar; 151 Suppl 1():S38-S42. PubMed ID: 28262232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes in an obstetrical population with hereditary thrombophilia and high tobacco use.
    Calhoun B; Hoover E; Seybold D; Broce M; Hill A; Schaible B; Bracero LA
    J Matern Fetal Neonatal Med; 2018 May; 31(10):1267-1271. PubMed ID: 28367651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia.
    Kupferminc M; Rimon E; Many A; Maslovitz S; Lessing JB; Gamzu R
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):123-6. PubMed ID: 21192252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of thrombophilia in adverse obstetric outcomes and their prevention using antithrombotic therapy.
    Grandone E; Tomaiuolo M; Colaizzo D; Ames PR; Margaglione M
    Semin Thromb Hemost; 2009 Oct; 35(7):630-43. PubMed ID: 20013530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study.
    Riyazi N; Leeda M; de Vries JI; Huijgens PC; van Geijn HP; Dekker GA
    Eur J Obstet Gynecol Reprod Biol; 1998 Sep; 80(1):49-54. PubMed ID: 9758259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of adverse perinatal outcome in inherited thrombophilias: a clinical study.
    Kosar A; Kasapoglu B; Kalyoncu S; Turan H; Balcik OS; Gümüs EI
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):14-8. PubMed ID: 21042205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment.
    Tincani A; Bazzani C; Zingarelli S; Lojacono A
    Semin Thromb Hemost; 2008 Apr; 34(3):267-73. PubMed ID: 18720306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of thrombosis during pregnancy.
    Vilela VS; de Jesús NR; Levy RA
    Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment and management of high-risk pregnancies in women with thrombophilia.
    Sarig G; Vidergor G; Brenner B
    Blood Rev; 2009 Jul; 23(4):143-7. PubMed ID: 19135285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia.
    Kovo M; Schreiber L; Elyashiv O; Ben-Haroush A; Abraham G; Bar J
    Reprod Sci; 2015 Mar; 22(3):316-21. PubMed ID: 25001023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregnancy loss and thrombophilia: the elusive link.
    Bennett SA; Bagot CN; Arya R
    Br J Haematol; 2012 Jun; 157(5):529-42. PubMed ID: 22449204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence-based indications for thrombophilia screening.
    Lindhoff-Last E; Luxembourg B
    Vasa; 2008 Feb; 37(1):19-30. PubMed ID: 18512539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hereditary thrombophilia and fetal loss: a prospective follow-up study.
    Vossen CY; Preston FE; Conard J; Fontcuberta J; Makris M; van der Meer FJ; Pabinger I; Palareti G; Scharrer I; Souto JC; Svensson P; Walker ID; Rosendaal FR
    J Thromb Haemost; 2004 Apr; 2(4):592-6. PubMed ID: 15102013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
    Lefkou E; Varoudi K; Pombo J; Jurisic A; Jurisic Z; Contento G; Girardi G
    Biochem Pharmacol; 2020 Dec; 182():114217. PubMed ID: 32926874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Thrombophilia and pregnancy. Prevention of maternal thrombotic and placental risks].
    Ann Med Interne (Paris); 2003; 154(5-6):422-30. PubMed ID: 15027600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.